Systemic Prolidase Activity and Oxidative Stress in Keratoconus

REFERENCES

• Rabinowitz YS. Keratoconus. Surv Ophthalmol 1998;42:297–319
   PubMed Web of Science ®Google Scholar
• Grünauer-Kloevekorn C, Duncker GI. Keratoconus: epidemiology, risk factors and diagnosis. Klin Monbl Augenheilkd 2006;223:493–502
   PubMed Web of Science ®Google Scholar
• Wagoner MD, Gonnah el-S, Al-Towerki AE; King Khaled Eye Specialist Hospital Cornea Transplant Study Group. Outcome of primary adult penetrating keratoplasty in a Saudi Arabian population. Cornea 2009;28:882–890
   PubMed Web of Science ®Google Scholar
• Zare M, Javadi MA, Einollahi B, Karimian F, Rafie AR, Feizi S, Azimzadeh A. Changing indications and surgical techniques for corneal transplantation between 2004 and 2009 at a tertiary referral center. Middle East Afr J Ophthalmol 2012;19:323–329
   PubMedGoogle Scholar
• Chang HY, Chodosh J. The genetics of keratoconus. Semin Ophthalmol 2013;28:275–280
   PubMed Web of Science ®Google Scholar
• Vazirani J, Basu S. Keratoconus: current perspectives. Clin Ophthalmol 2013;7:2019–2030
   PubMedGoogle Scholar
• Buddi R, Lin B, Atilano SR, Zorapapel NC, Kenney MC, Brown DJ. Evidence of oxidative stress in human corneal diseases. J Histochem Cytochem 2002;50:341–351
   PubMed Web of Science ®Google Scholar
• Kenney MC, Chwa M, Atilano SR, Tran A, Carballo M, Saghizadeh M, et al. Increased levels of catalase and cathepsin V/L2 but decreased TIMP-1 in keratoconus corneas: evidence that oxidative stress plays a role in this disorder. Invest Ophthalmol Vis Sci 2005;46:823–832
   PubMed Web of Science ®Google Scholar
• Wojcik KA, Blasiak J, Szaflik J, Szaflik JP. Role of biochemical factors in the pathogenesis of keratoconus. Acta Biochim Pol 2014;61:55–62
   PubMed Web of Science ®Google Scholar
• Zitka O, Kukacka J, Krizkova S, Huska D, Adam V, Masarik M, et al. Matrix metalloproteinases. Curr Med Chem 2010;17:3751–3768
   PubMed Web of Science ®Google Scholar
• Smith VA, Matthews FJ, Majid MA, Cook SD. Keratoconus: matrix metalloproteinase-2 activation and TIMP modulation. Biochim Biophys Acta 2006;1762:431–439
   PubMed Web of Science ®Google Scholar
• Seppala HPS, Maatta M, Routia M, Mackiewicz Z, Tuisku I, Tervo T, Konttinen YT. EMMPRIN and MMP-1 in keratoconus. Cornea. 2006;25:325–330
   PubMed Web of Science ®Google Scholar
• Mathews FJ, Cook SD, Majid MA, Dick AD, Smith VA. Change in the balance of the tissue inhibitor of matrix metalloproteinases (TIMPs)-1 and -3 may promote keratocyte apoptosis in keratoconus. Exp Eye Res 2007;84:1125–1134
   PubMed Web of Science ®Google Scholar
• Ollivier FJ, Gilger BC, Barrie KP, Kallberg ME, Plummer CE, O’Reilly S, et al. Proteinases of the cornea and preocular tear film. Vet Ophthalmol 2007;10:199–206
   PubMed Web of Science ®Google Scholar
• Palka JA, Phang JM. Prolidase activity in fibroblasts is regulated by interaction of extracellular matrix with cell surface integrin receptors. J Cell Biochem 1997;67:166–175
   PubMed Web of Science ®Google Scholar
• Uçakhan ÖÖ, Cetinkor V, Özkan M, Kanpolat A. Evaluation of Scheimpflug imaging parameters in subclinical keratoconus, keratoconus, and normal eyes. J Cataract Refract Surg 2011;37:1116–1124
   PubMed Web of Science ®Google Scholar
• Krumeich JH, Kezirian GM. Circular keratotomy to reduce astigmatism and improve vision in stage I and II keratoconus. J Refract Surg 2009;25:357–365
   PubMed Web of Science ®Google Scholar
• Myara I, Charpentier C, Lemonnier A. Optimal conditions for prolidase assay by proline colorimetric determination: application to iminodipeptiduria. Clin Chim Acta 1982;125:193–205
   PubMed Web of Science ®Google Scholar
• Chwa M, Atilano SR, Reddy V, Jordan N, Kim DW, Kenney MC. Increased stress-induced generation of reactive oxygen species and apoptosis in human keratoconus fibroblasts. Invest Ophthalmol Vis Sci 2006;47:1902–1910
   PubMed Web of Science ®Google Scholar
• Chwa M, Atilano SR, Hertzog D, Jordan N, Kim DW, Kenney MC. Hypersensitive response to oxidative stress in keratoconus corneal fibroblasts. Invest Ophthalmol Vis Sci 2008;49:4361–4369
   PubMed Web of Science ®Google Scholar
• Atilano SR, Chwa M, Kim DW, Jordan N, Udar N, Coskun P, et al. Hydrogen peroxide causes mitochondrial DNA damage in corneal epithelial cells. Cornea 2009;28:426–433
   PubMed Web of Science ®Google Scholar
• Arnal E, Peris-Martínez C, Menezo JL, Johnsen-Soriano S, Romero FJ. Oxidative stress in keratoconus? Invest Ophthalmol Vis Sci 2011;52:8592–8597
   PubMed Web of Science ®Google Scholar
• Toprak I, Kucukatay V, Yildirim C, Kilic-Toprak E, Kilic-Erkek O. Increased systemic oxidative stress in patients with keratoconus. Eye (Lond) 2014;28:285–289
   PubMed Web of Science ®Google Scholar
• Myara I, Charpentier C, Lemonnier A. Prolidase and prolidase deficiency. Life Sci 1984;34:1985–1998
   PubMed Web of Science ®Google Scholar
• Surazynski A, Miltyk W, Palka J, Phang JM. Prolidase-dependent regulation of collagen biosynthesis. Amino Acids 2008;35:731–738
   PubMed Web of Science ®Google Scholar
• Mock WL, Green PC. Mechanism and inhibition of prolidase. J Biol Chem 1990;265:19606–19610
   PubMed Web of Science ®Google Scholar
• Palka JA, Phang JM. Prolidase activity in fibroblasts is regulated by interaction of extracellular matrix with cell surface integrin receptors. J Cell Biochem 1997;67:166–175
   PubMed Web of Science ®Google Scholar
• Jackson SH, Dennis AW, Greenberg M. Iminodipeptiduria: a genetic defect in recycling collagen: a method for determining prolidase in erythrocytes. Can Med Assoc J 1975;113:759, 762–763
   Web of Science ®Google Scholar
• Kavala M, Zindanci I, Sudogan S, Turkoglu Z, Sarigul S. Ulcus cruris associated with prolidase deficiency. Dermatol Online J 2006;12:24
   PubMedGoogle Scholar
• Pierard GE, Cornil F, Lapiere CM. Pathogenesis of ulcerations in deficiency of prolidase. Am J Dermatopathol 1984;6:491–498
   PubMed Web of Science ®Google Scholar
• Shrinath M, Walter JH, Haeney M, Couriel JM, Lewis MA, Herrick AL. Prolidase deficiency and systemic lupus erythematosus. Arch Dis Child 1997;76:441–444
   PubMed Web of Science ®Google Scholar
• Cleary MA, Haeney M, Couriel JM, Walter JH. Immune function in prolidase deficiency. J Inherit Metab Dis 1994;17:345–348
   PubMed Web of Science ®Google Scholar
• Kıratlı H, Satılmış M. Prolidase deficiency associated with pathologic myopia. Ophthalmic Genet 1998;19:49–53
   PubMed Web of Science ®Google Scholar
• Myara I, Myara A, Mangeot M, Fabre M, Charpentier C, Lemonnier A. Plasma prolidase activity: a possible index of collagen catabolism in chronic liver disease. Clin Chem 1984;30:211–215
   PubMed Web of Science ®Google Scholar
• Duong HS, Zhang QZ, Le AD, Kelly AP, Kamdar R, Messadi DV. Elevated prolidase activity in keloids: correlation with type I collagen turnover. Br J Dermatol 2006;154:820–828
   PubMed Web of Science ®Google Scholar
• Akçakoyun M, Pala S, Esen O, Acar G, Kargin R, Emiroglu Y, et al. Dilatation of the ascending aorta is associated with low serum prolidase activity. Tohoku J Exp Med 2010;220:273–277
   PubMed Web of Science ®Google Scholar
• Yildiz A, Demirbag R, Yilmaz R, Gur M, Altiparmak IH, Akyol S, et al. The association of serum prolidase activity with the presence and severity of coronary artery disease. Coron Artery Dis 2008;19:319–325
   PubMed Web of Science ®Google Scholar
• Uçar D, Em S, Bozkurt M, Oktayoglu P, Yüksel HK, Caglayan M, et al. Serum prolidase activity in ankylosing spondylitis and rheumatoid arthritis. Clin Med Insights Arthritis Musculoskelet Disord 2013;6:29–33
   PubMedGoogle Scholar
• Bron AJ. The architecture of the corneal stroma. Br J Ophthalmol 2001;85:379–381
   PubMed Web of Science ®Google Scholar